As of close of business last night, Cardlytics Inc’s stock clocked out at $8.19, down -4.83% from its previous closing price of $8.60. In other words, the price has decreased by -$0.41 from its previous closing price. On the day, 1063124 shares were traded. CDLX stock price reached its highest trading level at $8.60 during the session, while it also had its lowest trading level at $7.94.
Ratios:
To gain a deeper understanding of CDLX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.15 and its Current Ratio is at 1.15. In the meantime, Its Debt-to-Equity ratio is 1.16 whereas as Long-Term Debt/Eq ratio is at 1.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Lake Street on November 29, 2023, initiated with a Buy rating and assigned the stock a target price of $13.
On September 08, 2022, Wells Fargo Downgraded its rating to Underweight which previously was Equal Weight and also lowered its target price recommendation from $14 to $13.
Wells Fargo Downgraded its Overweight to Equal Weight on July 14, 2022, whereas the target price for the stock was revised from $72 to $15.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 04 ’24 when Temsamani Karim Saad sold 34,515 shares for $7.89 per share. The transaction valued at 272,323 led to the insider holds 327,298 shares of the business.
Gupta Amit sold 72,658 shares of CDLX for $443,286 on Jan 24 ’24. The Chief Operating Officer now owns 102,342 shares after completing the transaction at $6.10 per share. On Jan 12 ’24, another insider, SOSIN CLIFFORD, who serves as the 10% Owner of the company, sold 17,155 shares for $7.00 each. As a result, the insider received 120,128 and left with 5,361,961 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDLX now has a Market Capitalization of 321.30M and an Enterprise Value of 493.49M. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.06 while its Price-to-Book (P/B) ratio in mrq is 1.40. Its current Enterprise Value per Revenue stands at 1.63 whereas that against EBITDA is -1.32.
Stock Price History:
Over the past 52 weeks, CDLX has reached a high of $19.57, while it has fallen to a 52-week low of $2.57. The 50-Day Moving Average of the stock is 7.10, while the 200-Day Moving Average is calculated to be 9.79.
Shares Statistics:
It appears that CDLX traded 769.33K shares on average per day over the past three months and 597.38k shares per day over the past ten days. A total of 39.25M shares are outstanding, with a floating share count of 36.27M. Insiders hold about 7.59% of the company’s shares, while institutions hold 74.40% stake in the company. Shares short for CDLX as of Feb 29, 2024 were 4.36M with a Short Ratio of 5.66, compared to 4.16M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 11.10% and a Short% of Float of 12.85%.
Earnings Estimates
As of right now, 3 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of $0.12 for the current quarter, with a high estimate of $0.25 and a low estimate of $0.03, while EPS last year was -$0.29. The consensus estimate for the next quarter is -$0.21, with high estimates of -$0.03 and low estimates of -$0.34.
Analysts are recommending an EPS of between -$0.21 and -$0.38 for the fiscal current year, implying an average EPS of -$0.29. EPS for the following year is -$0.07, with 3 analysts recommending between $0.68 and -$0.63.
Revenue Estimates
In the current quarter, 3 analysts expect revenue to total $89.55M. It ranges from a high estimate of $89.63M to a low estimate of $89.5M. As of the current estimate, Cardlytics Inc’s year-ago sales were $82.5M, an estimated increase of 8.50% from the year-ago figure. For the next quarter, 3 analysts are estimating revenue of $66.46M, an increase of 3.30% less than the figure of $8.50% in the same quarter last year. There is a high estimate of $68M for the next quarter, whereas the lowest estimate is $63.57M.
A total of 3 analysts have provided revenue estimates for CDLX’s current fiscal year. The highest revenue estimate was $309.66M, while the lowest revenue estimate was $304.26M, resulting in an average revenue estimate of $307.84M. In the same quarter a year ago, actual revenue was $298.54M, up 3.10% from the average estimate. Based on 3 analysts’ estimates, the company’s revenue will be $328.22M in the next fiscal year. The high estimate is $333.9M and the low estimate is $317.57M. The average revenue growth estimate for next year is up 6.60% from the average revenue estimate for this year.
